PAMU
ALDR

Pictet Asset Management (UK)’s Alder Biopharmaceuticals ALDR Stock Holding History

Pictet Asset Management (UK)’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-291,120
Closed -$3.7M – 920
2018
Q1 		$3.7M Sell
291,120
-1,674,351
-85% -$24.2M 0.01% 714
2017
Q4 		$22.5M Buy
1,965,471
+314,931
+19% +$3.52M 0.06% 366
2017
Q3 		$20.2M Buy
1,650,540
+1,014,290
+159% +$10.6M 0.06% 362
2017
Q2 		$9.8M Buy
636,250
+24,544
+4% +$454K 0.03% 481
2017
Q1 		$12.7M Buy
611,706
+251,249
+70% +$5.56M 0.04% 435
2016
Q4 		$7.5M Buy
360,457
+167,821
+87% +$4.36M 0.03% 504
2016
Q3 		$6.31M Sell
192,636
-240,418
-56% -$7.32M 0.02% 533
2016
Q2 		$13M Buy
433,054
+353,254
+443% +$9.56M 0.05% 377
2016
Q1 		$1.51M Buy
79,800
+19,400
+32% +$449K 0.01% 724
2015
Q4 		$2M Buy
60,400
+14,000
+30% +$473K 0.01% 724
2015
Q3 		$1.52M Buy
46,400
+2,300
+5% +$97.8K 0.01% 746
2015
Q2 		$2.05M Sell
44,100
-18,600
-30% -$676K 0.01% 745
2015
Q1 		$1.6M Buy
+62,700
New +$1.72M 0.01% 769

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pictet Asset Management (UK)'s ALDR Position: Q2 2018 in Review

Pictet Asset Management (UK) sold out of Alder Biopharmaceuticals (ALDR) in Q2 2018, closing a stake of 291,120 shares — an estimated $3.7M sold.

Pictet Asset Management (UK) first reported a position in ALDR in Q1 2015 and held it in 13 quarters. The position peaked at $22.5M in Q4 2017. 139 funds tracked by Wall St. Rank hold ALDR as of Q2 2018.

  • Pictet Asset Management (UK) reported no remaining Alder Biopharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 291,120 Alder Biopharmaceuticals shares in Q2 2018, an estimated $3.7M.
  • Pictet Asset Management (UK) first reported a position in Alder Biopharmaceuticals in Q1 2015 and held it in 13 quarters.
  • Pictet Asset Management (UK)'s Alder Biopharmaceuticals position peaked at $22.5M in Q4 2017.
  • 139 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2018.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2018, filed 13 Aug 2018.